Suppr超能文献

光学相干断层扫描引导下的光动力疗法再治疗

Optical coherence tomography guided retreatment of photodynamic therapy.

作者信息

Krebs I, Binder S, Stolba U, Schmid K, Glittenberg C, Brannath W, Goll A

机构信息

Department of Ophthalmology, Rudolf Foundation Clinic, Juchgasse 25, 1030 Vienna, Austria.

出版信息

Br J Ophthalmol. 2005 Sep;89(9):1184-7. doi: 10.1136/bjo.2005.067389.

Abstract

AIM

To evaluate the results of a retreatment modality of photodynamic therapy (PDT) based on optical coherence tomography (OCT) and fluorescein angiography (FA). To quantify the effect of PDT with the help of measurement of the retinal thickness.

METHODS

Eyes with predominantly classic subfoveal choroidal neovascularisation (CNV) due to age related macular degeneration were included. PDT was performed every three months, when needed. OCT, FA, and measures of distance acuity were performed at baseline, after 6 weeks, 3 months, and from then on every 3 months. A control group of a consecutive series of eyes that had been retreated based only on FA results was installed.

RESULTS

Forty eyes of 38 patients were included. The average age was 73 years. The maximum retinal thickness decreased from 404 mum at baseline to 281.6 mum at month 12. Furthermore there was a significant decrease of retinal thickness in both subgroups. The number of retreatments was reduced, when activity was diagnosed using OCT and FA. (2.4 v 4.0). The distance acuity correlated significantly with the maximum retinal thickness (p=0.0042).

CONCLUSION

Information about the activity of a neovascular lesion can be obtained with the help of OCT. The retreatment modalities can be optimised by using OCT and FA and the number of retreatments can be reduced.

摘要

目的

评估基于光学相干断层扫描(OCT)和荧光素血管造影(FA)的光动力疗法(PDT)再治疗模式的效果。借助测量视网膜厚度来量化PDT的效果。

方法

纳入因年龄相关性黄斑变性导致主要为经典性黄斑中心凹下脉络膜新生血管(CNV)的眼睛。必要时每三个月进行一次PDT。在基线、6周、3个月时以及此后每3个月进行OCT、FA和远视力测量。设立一个仅基于FA结果进行再治疗的连续系列眼睛的对照组。

结果

纳入38例患者的40只眼睛。平均年龄为73岁。最大视网膜厚度从基线时的404μm降至第12个月时的281.6μm。此外,两个亚组的视网膜厚度均显著降低。当使用OCT和FA诊断活动性时,再治疗次数减少(2.4对4.0)。远视力与最大视网膜厚度显著相关(p = 0.0042)。

结论

借助OCT可获取有关新生血管病变活动性的信息。通过使用OCT和FA可优化再治疗模式并减少再治疗次数。

相似文献

1
Optical coherence tomography guided retreatment of photodynamic therapy.
Br J Ophthalmol. 2005 Sep;89(9):1184-7. doi: 10.1136/bjo.2005.067389.
4
Optical coherence tomography to monitor photodynamic therapy in pathological myopia.
Br J Ophthalmol. 2006 May;90(5):555-8. doi: 10.1136/bjo.2005.085555. Epub 2006 Feb 7.
5
Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization.
Retina. 2011 May;31(5):871-9. doi: 10.1097/IAE.0b013e3182003ca8.
7
One-year outcomes of less frequent bevacizumab in age-related macular degeneration.
Retina. 2011 Apr;31(4):645-53. doi: 10.1097/IAE.0b013e3182012d18.
8
Correlation of high-definition optical coherence tomography and fluorescein angiography imaging in neovascular macular degeneration.
Invest Ophthalmol Vis Sci. 2009 Oct;50(10):4926-33. doi: 10.1167/iovs.09-3610. Epub 2009 Jun 3.
9
Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration.
Ophthalmology. 2007 Oct;114(10):1868-75. doi: 10.1016/j.ophtha.2007.04.030. Epub 2007 Jul 12.

引用本文的文献

1
Photodynamic therapy monitoring with optical coherence angiography.
Sci Rep. 2017 Feb 2;7:41506. doi: 10.1038/srep41506.
2
In-vivo investigation of laser-induced choroidal neovascularization in rat using spectral-domain optical coherence tomography (SD-OCT).
Graefes Arch Clin Exp Ophthalmol. 2013 May;251(5):1293-301. doi: 10.1007/s00417-012-2185-3. Epub 2012 Nov 1.
4
Predictors of response after intravitreal bevacizumab injection for neovascular age-related macular degeneration.
Jpn J Ophthalmol. 2010 Nov;54(6):571-7. doi: 10.1007/s10384-010-0866-1. Epub 2010 Dec 30.
5
Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.
Chem Rev. 2010 May 12;110(5):2795-838. doi: 10.1021/cr900300p.
6
Relationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degeneration.
Ophthalmology. 2008 Dec;115(12):2206-14. doi: 10.1016/j.ophtha.2008.08.016. Epub 2008 Oct 18.
7
Activity of neovascular lesions treated with bevacizumab: comparison between optical coherence tomography and fluorescein angiography.
Graefes Arch Clin Exp Ophthalmol. 2008 Jun;246(6):811-5. doi: 10.1007/s00417-007-0755-6. Epub 2008 Jan 15.
8
Optical coherence tomography analysis of a randomized study combining photodynamic therapy with intravitreal triamcinolone.
Graefes Arch Clin Exp Ophthalmol. 2008 Feb;246(2):245-54. doi: 10.1007/s00417-007-0642-1. Epub 2007 Aug 3.
9
Prognosis of untreated occult choroidal neovascularization.
Graefes Arch Clin Exp Ophthalmol. 2007 Mar;245(3):376-84. doi: 10.1007/s00417-006-0424-1. Epub 2006 Oct 27.
10
A new treatment regimen in combined intravitreal injection of triamcinolone acetonide and photodynamic therapy.
Graefes Arch Clin Exp Ophthalmol. 2006 Jul;244(7):863-7. doi: 10.1007/s00417-005-0155-8. Epub 2005 Dec 6.

本文引用的文献

1
Reading ability and central visual field after photodynamic therapy.
Ophthalmologica. 2004 May-Jun;218(3):185-92. doi: 10.1159/000076843.
4
Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy.
Am J Ophthalmol. 2003 Feb;135(2):169-77. doi: 10.1016/s0002-9394(02)01837-8.
5
Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization.
Am J Ophthalmol. 2002 Oct;134(4):566-76. doi: 10.1016/s0002-9394(02)01566-0.
6
Intravitreal triamcinolone for refractory diabetic macular edema.
Ophthalmology. 2002 May;109(5):920-7. doi: 10.1016/s0161-6420(02)00975-2.
10
Reproducibility of retinal mapping using optical coherence tomography.
Arch Ophthalmol. 2001 Aug;119(8):1135-42. doi: 10.1001/archopht.119.8.1135.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验